1-(4-氟苯基)-2-丙烯-1-酮 | 51594-59-3

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(4-氟苯基)-2-丙烯-1-酮
• 英文名称: 1-(4-fluorophenyl)-2-propen-1-one
• 英文别名: 1-(4-fluorophenyl)prop-2-en-1-one
• CAS: 51594-59-3
• 化学式: C₉H₇FO
• 分子量: 150.152
• InChiKey: HDQOQFCURUKAJI-UHFFFAOYSA-N

物化性质

• 沸点：
  216.4±32.0 °C(Predicted)
• 密度：
  1.097±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914700090

SDS

1-(4-氟苯基)-2-丙烯-1-酮MSDS英文版

反应信息

• 作为反应物：
  描述：

  1-(4-氟苯基)-2-丙烯-1-酮 在 吡啶 、 2-(2-hydroxyethyl)-3-methyl-4-benzylthiazolium chloride 、 溶剂黄146 、 三乙胺 、 potassium iodide 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 39.0h， 生成 3-[2-(4-Fluoro-phenyl)-5-isopropyl-pyrrol-1-yl]-butyronitrile
  参考文献：
  名称：

  Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-Pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus

  摘要：

  A novel series of trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones and their dihydroxy acid derivatives were prepared and evaluated for their ability to inhibit the enzyme HMG-CoA reductase in vitro. A systematic study of substitution at the 2- and 5-positions of the pyrrole ring revealed that optimum potency was realized with the 2-(4-fluorophenyl)-5-isopropyl derivative 8x, which possessed 30% of the in vitro activity of the potent fungal metabolite compactin (I). A molecular modeling analysis led to the description of a pharmacophore model characterized by (A) length limits of 5.9 and 3.3 A for the 2- and 5-substituents, respectively, as well as an overall width limit of 10.6 A across the pyrrole ring from the 2- to the 5-substituent and (B) an orientation of the ethyl(ene) bridge to the 4-hydroxypyran-2-one ring nearly perpendicular to the planes of the parent pyrrole, hexahydronaphthalene, and phenyl rings of the structures examined (Figure 3, theta = 80-110 degrees). Attempts to more closely mimic compactin's polar isobutyric ester side chain with the synthesis of 2-phenylpyrroles containing polar phenyl substituents resulted in analogues with equal or slightly reduced potencies when compared to the 2-[(unsubstituted or 4-fluoro)phenyl]pyrroles, supporting the hypothesis that inhibitory potency is relatively insensitive to side-chain polarity or charge distribution in this area.

  DOI：

  10.1021/jm00163a005
• 作为产物：
  描述：

  4'-氟苯丙酮 在 2,2'-联吡啶 、 2,2,6,6-四甲基哌啶氧化物 、 copper diacetate 作用下， 以 氯苯 为溶剂， 反应 10.0h， 生成 1-(4-氟苯基)-2-丙烯-1-酮
  参考文献：
  名称：

  由具有多个C（sp 3）–H键官能化和C–C键裂解和重组特征的饱和酮和Hy合成4-酰基吡唑

  摘要：

  本文报道了通过铜催化的饱和酮与的一锅级联反应，一种高效便捷的一锅合成多种取代的4-酰基吡唑衍生物的方法。从机理上讲，标题化合物的形成涉及通过饱和酮的脱氢和and的[2 + 3]环化原位形成烯酮中间体，然后进行芳构化驱动的C–C键裂解和重组。据我们所知，这是第一个实例，其中生物学上和药学上重要但又难以获得的4-酰基吡唑衍生物是直接由具有多种脂族C–H键功能化和CC键断裂的饱和酮和制备的。和重组。与文献方法相比，

  DOI：

  10.1021/acs.joc.7b01013

文献信息

• [EN] 7-PHENYL-ISOQUINOLINE-5-SULFONYLAMINO DERIVATIVES AS INHIBITORS OF AKT (PROTEINKINASE B)<br/>[FR] DERIVES DE 7-PHENYL-ISOQUINOLINE-5-SULFONYLAMINO EN TANT QU'INHIBITEURS DE AKT (PROTEINE KINASE B)
  申请人：LILLY CO ELI

  公开号：WO2005054202A1

  公开（公告）日：2005-06-16

  The present invention relates to compounds Formula (I) as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.

  本发明涉及化合物式（I）作为AKT活性抑制剂，用于治疗易感的肿瘤和病毒感染。
• PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME
  申请人：Mikoshiba Katsuhiko

  公开号：US20120277423A1

  公开（公告）日：2012-11-01

  The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3: wherein R 1 is a substituted or unsubstituted aryl or heterocyclyl group, R 2 , R 3 , and R 4 are hydrogen atoms, n is 2, X is halogen, R 5 and R 6 independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R 5 and R 6 are not hydrogen atoms at the same time, or R 5 and R 6 may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.

  本发明涉及：一种具有转谷氨酰胺酶抑制活性的酮化合物，由下式1、2或3表示： 其中R1是取代或未取代的芳基或杂环基团，R2、R3和R4是氢原子，n是2，X是卤素，R5和R6独立地表示氢原子或取代或未取代的C1-C10烷基、芳基或芳烷基团，其中R5和R6不同时为氢原子，或者R5和R6可以共同形成含氮原子（N）的饱和或未饱和的、取代或未取代的杂环基团；包含该化合物的蛋白质交联抑制剂；以及包含该化合物或蛋白质交联抑制剂的用于预防或治疗由蛋白质交联引起的疾病的组合物。
• Transition Metal-Free α-Csp³-H Methylenation of Ketones to Form C═C Bond Using Dimethyl Sulfoxide as Carbon Source
  作者：Yu-Feng Liu、Peng-Yi Ji、Jing-Wen Xu、Yu-Qun Hu、Qiang Liu、Wei-Ping Luo、Can-Cheng Guo

  DOI：10.1021/acs.joc.7b00619

  日期：2017.7.21

  metal-free reaction condition. Various aryl ketone derivatives react readily with DMSO, producing the α,β-unsaturated carbonyl compounds in yields of 42 to 90%. This method features a transition metal-free reaction condition, wide substrate scope and using DMSO as novel one-carbon source to form C═C bond, thus providing an efficient and expeditious approach to an important class of α,β-unsaturated carbonyl

  直接α-CSP 3 -H arylketones使用二甲亚砜作为单碳源过渡不含金属的反应条件下实现的，以形成C = C键的亚甲基化。各种芳基酮衍生物容易与DMSO反应，生成α，β-不饱和羰基化合物，产率为42％至90％。该方法具有无过渡金属的反应条件，较宽的底物范围以及使用DMSO作为新型一碳源形成C═C键的特点，从而为一种重要的α，β-不饱和羰基化合物提供了有效而快捷的方法。基于初步实验，揭示了这种转化的合理机制。
• Highly Efficient Route to Functionalized Tetrahydrocarbazoles Using a Tandem Cross-Metathesis/Intramolecular-Hydroarylation Sequence
  作者：Xiao-Lei An、Jia-Rong Chen、Chang-Feng Li、Fu-Gen Zhang、You-Quan Zou、Ying-Cen Guo、Wen-Jing Xiao

  DOI：10.1002/asia.201000315

  日期：——

  The scope of the novel ruthenium‐catalyzed tandem cross‐metathesis/intramolecular‐hydroarylation sequence is described. This methodology offers a practical and efficient synthesis of structurally diverse and complex tetrahydrocarbazoles in good to excellent yields (up to 98 %). Moreover, preliminary efforts towards the development of an enantioselective version of the current process by sequential

  描述了新型钌催化的串联交叉复分解/分子内氢芳基化序列的范围。这种方法可以有效，高效地合成结构多样且复杂的四氢咔唑（高达98％）。而且，提出了通过用钌配合物和手性胺的顺序催化来开发当前方法的对映选择性形式的初步努力，其具有高收率和对映选择性（高达88％的收率和91％的ee）。
• Indium(III)‐Catalyzed Hydration and Hydroalkoxylation of α,β‐Unsaturated Ketones in Aqueous Media
  作者：Jin‐Jin Yun、Man‐Ling Zhi、Wen‐Xiao Shi、Xue‐Qiang Chu、Zhi‐Liang Shen、Teck‐Peng Loh

  DOI：10.1002/adsc.201800301

  日期：2018.7.16

  The hydration of α,β‐unsaturated ketones with water proceeded efficiently in the presence of In(OTf)3 (20 mol%) in aqueous media to afford synthetically versatile β‐hydroxyketones in moderate to good yields with good functional group compatibility. The method also can be extended to the hydroalkoxylation of α,β‐unsaturated ketones with various alcohols for the efficient synthesis of β‐alkoxyketones as

  在水介质中存在In（OTf）3（20 mol％）的情况下，α，β-不饱和酮与水的水合作用有效地进行，从而以中等至良好的产率提供合成通用的β-羟基酮，并具有良好的官能团相容性。该方法还可以扩展到α，β-不饱和酮与各种醇的加氢烷氧基化反应，以有效合成β-烷氧基酮和四氢呋喃衍生物。